| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |